Drug Trial Radar · NCT07592689
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
165
Planned (sponsor's estimate)
Start
May 10, 2026
Primary completion
Sep 2027
Study completion Jun 2028
Sponsor
- Lead sponsor
- Definium Therapeutics US, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Ascend
Conditions
- Major Depressive Disorder
Interventions
PlaceboOther
A substance that is designed to have no therapeutic value
DT120Drug
A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score at Week 6Time frame: Baseline to Week 6
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Preferred Research Partners, Inc.
Little Rock, Arkansas · Recruiting
ATP Clinical Research Orange County
Orange, California · Recruiting
Kadima Neuropsychiatry Institute
San Diego, California · Recruiting
Psychedelic Science Institute
Santa Monica, California · Recruiting
Mountain View Clinical Research, Inc
Denver, Colorado · Recruiting
Clinical Neuroscience Solutions, LLC (Jacksonville)
Jacksonville, Florida · Recruiting
K2 Medical Research (Maitland)
Maitland, Florida · Recruiting
Clinical Neuroscience Solutions, LLC (Orlando)
Orlando, Florida · Recruiting
K2 Medical Research (Tampa)
Tampa, Florida · Recruiting
CenExel - Atlanta Center for Medical Research
Atlanta, Georgia · Recruiting
CenExel - iResearch Atlanta
Decatur, Georgia · Recruiting
CenExel - iResearch Savannah
Savannah, Georgia · Recruiting
Uptown Research Institute
Chicago, Illinois · Recruiting
Adams Clinical Boston
Boston, Massachusetts · Active not recruiting
Adams Clinical Watertown
Boston, Massachusetts · Recruiting
Vitalix Clinical
Worcester, Massachusetts · Recruiting
Arch Clinical Trials, LLC
St Louis, Missouri · Recruiting
Redbird Research
Las Vegas, Nevada · Recruiting
Adams Clinical Harlem
New York, New York · Active not recruiting
Adams Clinical Philadelphia
Philadelphia, Pennsylvania · Recruiting
Coastal Carolina Research
North Charleston, South Carolina · Recruiting
Austin Clinical Trial Partners
Austin, Texas · Recruiting
Cedar Clinical Research
Draper, Utah · Recruiting
Inner Space Research
Orem, Utah · Recruiting
Memory Clinic Inc.
Bennington, Vermont · Recruiting
Seattle Neuropsychiatric Treatment Center
Seattle, Washington · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.